Press release from Companies

Published: 2023-01-03 16:19:53

Redsense Medical AB: Partial delivery of record order

As communicated on December 2, 2022, Redsense Medical secured the company’s largest order to date valued at MSEK 15.20 from one of the company’s US distributors. A partial delivery valued around MSEK 4.75 was shipped and invoiced in December 2022. The balance of the order is planned for delivery in Q1 2023 and the company is working with the distributor on the logistics of the order.

"We are very pleased with the collaboration with our supply chain partners regarding the delivery plan and the prompt shipment of this part delivery of the larger order. With this delivery, we secure a strong finish of 2022 and look forward to keeping the momentum and an excellent start of 2023. As always, we continue our focus to promote and provide patient safety during hemodialysis" says Pontus Nobréus CEO of Redsense Medical AB.

 Contact information

For more information, please contact: 
Pontus Nobréus
CEO
Telephone: +46 72-171 1264
E-mail: 
pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.               

Läs mer hos Cision
Read more about Redsense Medical AB